Provided by Tiger Fintech (Singapore) Pte. Ltd.

Seres Therapeutics

7.36
-0.0500-0.67%
Volume:33.81K
Turnover:248.27K
Market Cap:64.27M
PE:0.82
High:7.49
Open:7.28
Low:7.14
Close:7.41
Loading ...

Seres Therapeutics sees cash runway into 1Q26

TIPRANKS
·
13 Mar

Seres Therapeutics Reported Q4 Net Loss From Continuing Operations Of $15.7M, Narrowing From A Year-Ago Loss Of $34.7M

Benzinga
·
13 Mar

BRIEF-Seres Therapeutics FY EPS USD 0

Reuters
·
13 Mar

Seres Therapeutics FY EPS USD 0

THOMSON REUTERS
·
13 Mar

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
13 Mar

Seres Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
05 Mar

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

GlobeNewswire
·
04 Mar

Positive Outlook for Seres Therapeutics: FDA Endorsement and Strategic Study Design Boost Buy Rating

TIPRANKS
·
04 Mar

Seres Therapeutics Inc - FDA Supports Primary Efficacy Endpoint for Ser-155 Study

THOMSON REUTERS
·
03 Mar

Seres Therapeutics Receives Feedback From FDA on Ser-155 Allogeneic Hematopoietic Stem Cell Transplant (Allo-Hsct) Development Approach

THOMSON REUTERS
·
03 Mar

Seres Therapeutics Inc - Expects FDA Response on Ser-155 Study Protocol in Weeks

THOMSON REUTERS
·
03 Mar

Seres Therapeutics Inc - Ser-155 Receives Breakthrough Therapy and Fast Track Designations

THOMSON REUTERS
·
03 Mar

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

GlobeNewswire
·
03 Mar

Seres Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
28 Feb

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
16 Jan

Seres Therapeutics Receives First of 2 Installments Related to VOWST Sale

MT Newswires Live
·
16 Jan

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to Vowst Sale

THOMSON REUTERS
·
16 Jan

Press Release: Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Dow Jones
·
16 Jan

Seres Therapeutics Reports 'Positive Impact' in SER-155 Early Trial; Cash Runway Extended

MT Newswires Live
·
10 Jan

Seres announces new translational biomarker results from SER-155 Phase 1b study

TIPRANKS
·
09 Jan